Back
74
Day Range
$83.53
$91.06
52-Week Range
$45.91
$122.20
Volume
951,015
50D / 200D Avg
$99.01
/
$96.18
Prev Close
$87.45
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -29.4 | 0.4 |
| P/B | 41.6 | 2.9 |
| ROE % | -129.5 | 3.8 |
| Net Margin % | -103.6 | 3.9 |
| Rev Growth 5Y % | 178.5 | 10.0 |
| D/E | 1.8 | 0.2 |
Analyst Price Target
Hold
$140.18
+65.6%
Low: $125.00
High: $157.00
Forward EPS
-$3.08
Est. Revenue
290 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$12.09
$8.29 – $14.94
|
1.9 B | 3 |
| FY2029 |
$7.49
$5.13 – $9.25
|
1.4 B | 3 |
| FY2028 |
$3.08
$0.10 – $5.89
|
900 M | 9 |
Key Takeaways
Revenue grew 178.51% annually over 5 years — strong growth
Negative free cash flow of -116.63M
Revenue growth is decelerating — 1Y growth trails 5Y average by 132.68%
Capital efficient — spends only 0.50% of revenue on capex
Growth
Revenue Growth (5Y)
178.51%
Revenue (1Y)45.83%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-129.46%
ROIC-37.35%
Net Margin-103.57%
Op. Margin-101.19%
Safety
Debt / Equity
1.77
Current Ratio4.41
Interest Coverage-9.33
Valuation
P/E Ratio
-29.41
P/B Ratio41.56
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 45.83% | Revenue Growth (3Y) | 56.55% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 178.51% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 189.76M | Net Income (TTM) | -196.54M |
| ROE | -129.46% | ROA | -40.84% |
| Gross Margin | 89.73% | Operating Margin | -101.19% |
| Net Margin | -103.57% | Free Cash Flow (TTM) | -116.63M |
| ROIC | -37.35% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1.77 | Current Ratio | 4.41 |
| Interest Coverage | -9.33 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -29.41 | P/B Ratio | 41.56 |
| P/S Ratio | 30.46 | PEG Ratio | 1.25 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 5.78B | Enterprise Value | 5.97B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 189.76M | 130.13M | 77.43M | 23.64M | 3.15M |
| Net Income | -196.54M | -260.60M | -184.68M | -181.12M | -69.61M |
| EPS (Diluted) | -3.11 | -4.34 | -3.20 | -3.51 | -1.37 |
| Gross Profit | 170.27M | 116.76M | 68.13M | 21.51M | 2.56M |
| Operating Income | -192.02M | -265.50M | -184.36M | -179.16M | -170.06M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 481.19M | 392.27M | 332.75M | 382.48M | 329.52M |
| Total Liabilities | 342.13M | 227.72M | 162.99M | 118.22M | 45.37M |
| Shareholders' Equity | 139.07M | 164.55M | 169.76M | 264.26M | 284.15M |
| Total Debt | 246.47M | 3.94M | 1.26M | 1.94M | 2.55M |
| Cash & Equivalents | 54.30M | 89.14M | 60.08M | 127.68M | 59.25M |
| Current Assets | 466.92M | 374.20M | 308.27M | 354.24M | 308.39M |
| Current Liabilities | 105.94M | 115.52M | 55.20M | 39.81M | 43.43M |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#9 of 146
Recent Activity
Entered
Full Throttle
Mar 24, 2026